Trial Profile
Neoadjuvant Sunitinib for Patients with Tumor Thrombus in Renal Cell Carcinoma: A Multicenter Analysis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Aug 2015
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 19 Aug 2015 New trial record